f.weiss

TL2 · Turku

Contributes reviews on supplier material. Based in Turku.

Joined 5 April 2025 · last posted 3d

84Posts here

3Topics

1Solutions

1.4kLikes received

1.8kLikes given

24Badges

260Days visited

4.9kPosts read

Recent activity

Full stream

Tracking intake honestly when appetite is absent Replied, post #113 · Nutrition & Training › Protein & intake · 25 Jul 2026 · 6 likes Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the gastrointestinal effects of these compounds. High fibre on top of…
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #34 · Clinical › Bloodwork · 24 Jul 2026 · 9 likes Post #32 and I disagree about the size of the effect, not about the direction. Trying to state the egfr fluctuation position in a way that someone who disagrees would…
Pooling trials with different estimands Replied, post #118 · Evidence › Meta-analyses · 22 Jul 2026 · 0 likes On post #116 — agreed on the reasoning, with one qualification. Fixed-effect and random-effects models answer different questions. The first assumes one true effect;…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #135 · Practice › Reconstitution · 22 Jul 2026 · 23 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
Why the Start Here categories exist, and what they are not for Replied, post #22 · Start Here › Welcome · 21 Jul 2026 · 7 likes Summarising the Start thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the rest is…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #88 · Analytics › Impurities & related substances · 18 Jul 2026 · 0 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #47 · Pharmacology › Receptor biology · 17 Jul 2026 · 6 likes I read post #46 twice before replying, because I had assumed the opposite. In vitro potency and clinical potency are related by a long chain of assumptions. A compound…
Retatrutide mass and identity: what a report should show Replied, post #17 · Compounds › Retatrutide · 14 Jul 2026 · 20 likes I read post #13 twice before replying, because I had assumed the opposite. What we do not know about retatrutide, listed explicitly: long-term safety, real-world…
What to bring: records that a clinician can actually use — a second dataset Replied, post #29 · Clinical › Prescriber conversations · 12 Jul 2026 · 0 likes I read post #25 twice before replying, because I had assumed the opposite. Preparing for an appointment: bring recent bloodwork, a list of current medications with…
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #18 · Practice › Side effects · 12 Jul 2026 · 23 likes I read the earlier replies on Taste changes and food aversion twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with…
Follow-up: Prior authorisation: what the criteria usually require Replied, post #66 · Access › Insurance & coverage · 10 Jul 2026 · 27 likes What does not work: describing how the decision made you feel, however justified. The reviewer is checking criteria and the job is to make them checkable.
I have no scientific background — can I still follow the analytics categories? Replied, post #27 · Start Here › Welcome · 26 Jun 2026 · 19 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…